| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Bottom |
| Cognigen Corporation - Posters and Presentations : Pre-2006 : 2004 : ICAAC 2004 | published Mon, Nov 10, 2008 - 15:27 EST |
| Name | Description | Page Modified |
| Monte Carlo Simulation to Estimate in VITRO susceptibility breakpoints for Moxifloxacin, Gatifloxacin, and Levofloxacin against Staphylococcus Aureus | Primary Cognigen Author: Alison Meagher, B.S., PharmD. | Mon Jan 21 14:05:24 EST 2008 |
| Population Pharmacokinetics of Tigecycline in Phase 1 Subjects | Primary Cognigen Author: Scott Van Wart, M.S. Primary Wyeth Author: Steve Troy | Mon Jan 21 14:05:24 EST 2008 |
| Population Pharmacokinetics of Doripenem | Primary Cognigen Author: Scott Van Wart, M.S. Primary Peninsula Pharmaceuticals Author: Matthew A. Wikler, | Mon Jan 21 14:05:24 EST 2008 |
| Cognigen Corporation - Posters and Presentations : Pre-2006 : 2004 : ICAAC 2004 | published Mon, Nov 10, 2008 - 15:27 EST |
| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Top |